Olema Pharmaceuticals, Inc. financial data

Symbol
OLMA on Nasdaq
Industry
Pharmaceutical Preparations
Location
780 Brannan Street, San Francisco, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 12, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 931 % -27%
Debt-to-equity 11.9 % +32.7%
Return On Equity -53.6 % -12.8%
Return On Assets -47.9 % -9.82%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 57.3M shares +4.62%
Common Stock, Shares, Outstanding 57.3M shares +4.92%
Entity Public Float 245M USD +105%
Common Stock, Value, Issued 4K USD 0%
Weighted Average Number of Shares Outstanding, Basic 57.3M shares +27.3%
Weighted Average Number of Shares Outstanding, Diluted 57.3M shares +27.3%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 118M USD +44.3%
General and Administrative Expense 17.8M USD -10.5%
Operating Income (Loss) -136M USD -33.6%
Nonoperating Income (Expense) 13.2M USD +132%
Net Income (Loss) Attributable to Parent -123M USD -27.7%
Earnings Per Share, Basic -2.17 USD/shares +6.47%
Earnings Per Share, Diluted -2.17 USD/shares +6.47%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 35.9M USD -69.4%
Marketable Securities, Current 179M USD +12.2%
Cash, Cash Equivalents, and Short-term Investments 215M USD -22.4%
Assets, Current 218M USD -22.7%
Property, Plant and Equipment, Net 849K USD -19.6%
Operating Lease, Right-of-Use Asset 1.57M USD -38.7%
Other Assets, Noncurrent 15K USD
Assets 230M USD -21.4%
Accounts Payable, Current 2.69M USD +21.7%
Employee-related Liabilities, Current 1.24M USD
Liabilities, Current 30.7M USD +92.3%
Operating Lease, Liability, Noncurrent 562K USD -66.9%
Liabilities 31.3M USD +77%
Accumulated Other Comprehensive Income (Loss), Net of Tax 464K USD
Retained Earnings (Accumulated Deficit) -402M USD -44%
Stockholders' Equity Attributable to Parent 199M USD -27.7%
Liabilities and Equity 230M USD -21.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -23.5M USD -15.2%
Net Cash Provided by (Used in) Financing Activities 8.82M USD +3910%
Net Cash Provided by (Used in) Investing Activities -20.1M USD -154%
Common Stock, Shares Authorized 490M shares 0%
Common Stock, Shares, Issued 57.3M shares +4.64%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -34.8M USD -302%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 35.9M USD -69.4%
Deferred Tax Assets, Valuation Allowance 71.6M USD +50.9%
Deferred Tax Assets, Gross 71.9M USD +50.4%
Operating Lease, Liability 1.7M USD -35.2%
Payments to Acquire Property, Plant, and Equipment 153K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -122M USD -30.3%
Lessee, Operating Lease, Liability, to be Paid 1.81M USD -38.2%
Property, Plant and Equipment, Gross 1.75M USD -7.1%
Operating Lease, Liability, Current 1.14M USD +23.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 263K USD -78.9%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.25M USD +7.14%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 114K USD -63.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 263K USD -68%
Deferred Tax Assets, Operating Loss Carryforwards 44.7M USD +62.9%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 69K USD -91.6%
Operating Lease, Payments 1.12M USD -13.3%
Additional Paid in Capital 600M USD +8.26%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 88K USD -12%
Share-based Payment Arrangement, Expense 20.6M USD +16%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%